BIOMAT Database Logo BIOMAT Database Logo

Furosemide as a displacing agent in assay of total triiodothyronine. 1991

W Groskopf, and B Green, and L Sohn, and S Hsu

UI MeSH Term Description Entries
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D005665 Furosemide A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY. Frusemide,Fursemide,Errolon,Frusemid,Furanthril,Furantral,Furosemide Monohydrochloride,Furosemide Monosodium Salt,Fusid,Lasix
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014284 Triiodothyronine A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3. Liothyronine,T3 Thyroid Hormone,3,3',5-Triiodothyronine,Cytomel,Liothyronine Sodium,Thyroid Hormone, T3

Related Publications

W Groskopf, and B Green, and L Sohn, and S Hsu
Triiodothyronine uptake assay with immobilized triiodothyronine antibody as the bound-free separating agent.
June 1977, Clinical chemistry,
W Groskopf, and B Green, and L Sohn, and S Hsu
Development of triiodothyronine uptake assay using acridine orange dye as the separating agent.
May 1984, Clinica chimica acta; international journal of clinical chemistry,
W Groskopf, and B Green, and L Sohn, and S Hsu
Protein binding and bilirubin displacing properties of bumetanide and furosemide.
January 1982, Journal of clinical pharmacology,
W Groskopf, and B Green, and L Sohn, and S Hsu
Relative ineffectiveness of exogenous triiodothyronine as a thyroid suppressive agent.
February 1983, Journal of endocrinological investigation,
W Groskopf, and B Green, and L Sohn, and S Hsu
Relative ineffectiveness of exogenous triiodothyronine as a thyroid suppressive agent.
January 1981, Journal of endocrinological investigation,
W Groskopf, and B Green, and L Sohn, and S Hsu
The binding of furosemide to serum proteins in elderly patients: displacing effect of phenprocoumon.
September 1980, Acta pharmacologica et toxicologica,
W Groskopf, and B Green, and L Sohn, and S Hsu
[Total triiodothyronine (total T3)].
March 1995, Nihon rinsho. Japanese journal of clinical medicine,
W Groskopf, and B Green, and L Sohn, and S Hsu
d (--) Methylfolic acid displacing agent for folic acid.
February 1947, Archives of biochemistry,
W Groskopf, and B Green, and L Sohn, and S Hsu
Triiodothyronine as an inotropic agent after open heart surgery.
November 1989, The Journal of thoracic and cardiovascular surgery,
W Groskopf, and B Green, and L Sohn, and S Hsu
[Total triiodothyronine (T3), free triiodothyronine (FT3), reverse triiodothyronine (rT3)].
December 1999, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!